Bulletin
Investor Alert

May 27, 2020, 5:15 a.m. EDT

Biochips Market Analysis as per the Latest Coronavirus Impact

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

May 27, 2020 (Heraldkeepers) -- New York, May 27, 2020: You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

Global Biochips Market share consists of several players including bioMerieux SA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.

The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.

Browse Full Report: https://www.marketresearchengine.com/biochips-market

Global Biochips Market is segmented based on the deployment model as Cloud and On-premise. The report segments global Biochips Market based on the basis of product, the market is divided into DNA chip, protein chip, lab-on-a-chip, and others. Based on end-user it covers biotechnology & pharmaceutical companies, hospitals & diagnostics centres, academic & research institutes, and others. Based on application it covers drug discovery & development, disease diagnostics, genomics, proteomics, agriculture, and others. Global Biochips Market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Biochips Market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

The Biochips Market is expected to exceed more than US$ 18.50 Billion by 2024. Biochip could be a miniaturized medical device utilized in molecular laboratories to hold out many organic chemistry reactions at the same time. It will rapidly screen variety of biological analytes for an array of applications like disease identification and detection of venturous biological agents in an exceedingly system. It’s designed on the premise of microarray and microfluidic technologies, among that digital microfluid chip is very efficient, and has gained vital quality within the biochemical field. Increase in prevalence of cancer, immunological disorders, and infective agent infections majorly drives the expansion of the worldwide biochips market. Alternative factors that boost the market growth embody rise in geriatric population, increase in range of chip applications, and high adoption of customized medications. However, factors like high value of chip and lack of information concerning it majorly in rising nations hamper the market growth. Conversely, rise in R&D investment in addition as government funding and high potential in untapped markets in rising economies are expected to produce lucrative growth opportunities for the market.

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include bioMerieux SA, Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, HORIBA, Ltd., Illumina, Inc., PerkinElmer, Inc., QIAGEN N.V., Randox Laboratories Ltd., and Thermo Fisher Scientific Inc.

Reasons to Buy this Report:

  • Gain comprehensive insights on the industry trends

  • Identify industry opportunities and key growth segments

  • Obtain complete market study on the Biochips Market

  • Facilitate strategy planning for your company based on the industry dynamics

  • Evaluate your competitor's business segments and portfolios

The Biochips Market has been segmented as below:

The Biochips Market is segmented on the lines of Biochips Market, By Product, Biochips Market, By Application, Biochips Market, By End-User and Biochips Market, By Region.

Biochips Market, By Product this market is segmented on the basis of DNA Chip, Protein Chip, Lab-on-a-chip and Others. Biochips Market, By Application this market is segmented on the basis of Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Others. Biochips Market, By End-User this market is segmented on the basis of Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes and Others. Biochips Market, By Region this market is segmented on the basis of North America, Europe, Asia Pacific and Rest of World.

The report covers:

  • Global Biochips Market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.

  • Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024.

  • Global Biochips Market trends, with detailed analysis on consumer trends & manufacturer trends.

  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.

  • Key areas of investments identifying market opportunities and challenges in forecast timeframe.

  • Competitive analysis of the industry players along with the overview on strategic management.

  • Comprehensive company profiles of the major industry players.

Report scope:

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.